Product
IL-17A antibody
1 clinical trial
1 indication
Indication
Axial SpondyloarthritisClinical trial
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Preliminary Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR1501 Injection by in Patients With Active Axial SpondyloarthritisStatus: Completed, Estimated PCD: 2021-07-30